FDA: New Merck HIV-fighting drug is safe
452190
A new HIV-fighting drug from Merck &amp; Co. appears superior to options for patients who have stopped responding to available drugs, federal regulators said Friday.
465386
An experimental HIV drug from Merck &amp; Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
539695
MONDAY, Feb. 14 (HealthDay News) -- A harmless version of HIV, the virus that causes AIDS, is being used to hunt down malignant melanoma cancer cells in mice, researchers say.
635733
A potent new anti-clotting drug from Eli Lilly and Co proved as safe and effective as Sanofi-Aventis's top-seller Plavix in a mid-stage clinical trial, researchers said on Sunday. Now Lilly and its partner Sankyo Co. Ltd. aim to demonstrate clear superiority for their compound, known as prasugrel or CS-747, in a much larger Phase III study involving up to 13,000 patients that is about to get under way.
211992
Doctors and AIDS activists in Africa are worried governments may halt use of an AIDS drug that has protected thousands of babies from HIV infection in reaction to new concerns about the drug's testing and effect on pregnant women.
333048
A naturally occurring molecule saves vital immune system cells from cellular suicide during the onslaught of the AIDS virus and might help keep the body's natural defenses working in HIV-infected people, a study found.
597708
Drug giant Merck says the Food and Drug Administration wants more information, but is prepared to approve the company&#39;s successor drug to recalled pain reliever Vioxx.
303787
A once-daily pill that combines three drugs used to treat HIV received federal approval Wednesday, giving U.S. patients the first triple "cocktail" therapy that can be swallowed as a single dose.
26961
Merck &amp; Co. said the US Food and Drug Administration has requested additional safety and efficacy information on its Vioxx successor, Arcoxia, before it considers granting US approval for the drug.
626150
Merck & Co Inc. won U.S. approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
438501
Here's what a newly approved drug looks like.
664769
The World Health Organization (WHO) said it would continue recommending use of the Viramune drug in AIDS patients despite a U.S. regulatory warning, as the benefits were greater than toxicity problems.
682689
An HIV-positive pregnant woman enrolled in a NIH study examining the ability of the antiretroviral drug nevirapine to prevent mother-to-child HIV transmission died of liver failure that likely was caused by the drug.
125021
Merck & Co. MRK.N on Friday said  U.S. regulators have decided not to approve the company's  experimental arthritis drug, the successor to its recalled  Vioxx pill, until more safety and effectiveness data are  obtained.
91514
A veteran U.S. Food and Drug  Administration scientist will unveil new data on Thursday  before an expert panel charged with determining whether pain  relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx  should remain on the market.